MDDV.F Stock Overview
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Medical Developments International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.31 |
| 52 Week High | AU$0.71 |
| 52 Week Low | AU$0.31 |
| Beta | 1.64 |
| 1 Month Change | -43.76% |
| 3 Month Change | -47.82% |
| 1 Year Change | -46.07% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -95.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDDV.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0.9% | -0.1% | 1.0% |
| 1Y | -46.1% | 13.6% | 27.2% |
Return vs Industry: MDDV.F underperformed the US Pharmaceuticals industry which returned 13.1% over the past year.
Return vs Market: MDDV.F underperformed the US Market which returned 25.7% over the past year.
Price Volatility
| MDDV.F volatility | |
|---|---|
| MDDV.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: MDDV.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MDDV.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | n/a | Brent MacGregor | medicaldev.com |
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices.
Medical Developments International Limited Fundamentals Summary
| MDDV.F fundamental statistics | |
|---|---|
| Market cap | US$24.29m |
| Earnings (TTM) | -US$12.72m |
| Revenue (TTM) | US$22.22m |
1.1x
P/S Ratio-1.9x
P/E RatioIs MDDV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDDV.F income statement (TTM) | |
|---|---|
| Revenue | AU$33.55m |
| Cost of Revenue | AU$10.17m |
| Gross Profit | AU$23.38m |
| Other Expenses | AU$42.59m |
| Earnings | -AU$19.21m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 69.69% |
| Net Profit Margin | -57.27% |
| Debt/Equity Ratio | 0% |
How did MDDV.F perform over the long term?
See historical performance and comparison